Alzheimer's and Dementia: Translational Research and Clinical Interventions
Impact Factor & Key Scientometrics

I. Basic Journal Info

Country

United States

Journal ISSN: 23528737

Publisher: John Wiley & Sons Inc.

History: 2015-2021

Journal Hompage: Link

How to Get Published:

Research Categories

Scope/Description:

AlzheimersDementia Translational ResearchClinical Interventions TRCI is a peerreviewed open accessjournal from the Alzheimers Association. The journal seeks to bridge the full scope of explorations between basic research on drug discovery and clinical studies validating putative therapies for agingrelated chronic brain conditions that affect cognition motor functions and other behavioral or clinical symptoms associated with all forms dementia and Alzheimers disease. The journal will publish findings from diverse domains of research and disciplines to accelerate the conversion of abstract facts into practical knowledge specifically to translate what is learned at the bench into bedside applications.The journal seeks to publish articles that go beyond a singular emphasis on either basic drug discovery research or clinical research. Rather an important theme of articles will be the linkages between and among the various discrete steps in the complex continuum of therapy development.For rapid communication among a multidisciplinary research audience involving the range of therapeutic interventions TRCI will consider only original contributions that include feature length research articles systematic reviews metaanalyses brief reports narrative reviews commentaries letters perspectives and research news that would advance wide range of interventions to ameliorate symptoms or alter the progression of chronic neurocognitive disorders such as dementia and Alzheimers disease.The journal will publish on topics related to medicine geriatrics neuroscience neurophysiology neurology psychiatry clinical psychology bioinformatics pharmacogenetics regulatory issues health economics pharmacoeconomics and public health policy as these apply to preclinical and clinical research on therapeutics.